InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease

F Scalafini; Richard A Adams; Cathy Eng; Al Benson III; Robert G.T. Glynne-Jones; David C. Montefiori; Dirk Arnold; Amitesh C. Roy; Marianne Grønlie  Guren; Eva Segelov; Matthew T Seymour; Annette  Bryant; Clare Peckitt; David Cunningham; John A.  Bridgewater

doi:10.1200/jco.2015.33.3_suppl.tps792

InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease

F Scalafini , Richard A Adams, Cathy Eng, Al Benson III, Robert G.T. Glynne-Jones, David C. Montefiori, Dirk Arnold, Amitesh C. Roy, Marianne Grønlie Guren, Eva Segelov, Matthew T Seymour, Annette Bryant, Clare Peckitt, David Cunningham, John A. Bridgewater

Research output: Contribution to conference › Poster

Original language	English
Number of pages	1
DOIs	https://doi.org/10.1200/jco.2015.33.3_suppl.tps792
Publication status	Published - 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2015.33.3_suppl.tps792

Cite this

Scalafini , F., Adams, R. A., Eng, C., Benson III, A., Glynne-Jones, R. G. T., Montefiori, D. C., Arnold, D., Roy, A. C., Guren, M. G., Segelov, E., Seymour, M. T., Bryant, A., Peckitt, C., Cunningham, D., & Bridgewater, J. A. (2015). InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease. https://doi.org/10.1200/jco.2015.33.3_suppl.tps792

@conference{3c1774a524de41c4b52ef3efad104052,

title = "InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease",

author = "F Scalafini and Adams, {Richard A} and Cathy Eng and {Benson III}, Al and Glynne-Jones, {Robert G.T.} and Montefiori, {David C.} and Dirk Arnold and Roy, {Amitesh C.} and Guren, {Marianne Gr{\o}nlie} and Eva Segelov and Seymour, {Matthew T} and Annette Bryant and Clare Peckitt and David Cunningham and Bridgewater, {John A.}",

year = "2015",

doi = "10.1200/jco.2015.33.3_suppl.tps792",

language = "English",

}

Scalafini , F, Adams, RA, Eng, C, Benson III, A, Glynne-Jones, RGT, Montefiori, DC, Arnold, D, Roy, AC, Guren, MG, Segelov, E, Seymour, MT, Bryant, A, Peckitt, C, Cunningham, D & Bridgewater, JA 2015, 'InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease'. https://doi.org/10.1200/jco.2015.33.3_suppl.tps792

InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease. / Scalafini , F; Adams, Richard A; Eng, Cathy et al.

2015.

Research output: Contribution to conference › Poster

TY - CONF

T1 - InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease

AU - Scalafini , F

AU - Adams, Richard A

AU - Eng, Cathy

AU - Benson III, Al

AU - Glynne-Jones, Robert G.T.

AU - Montefiori, David C.

AU - Arnold, Dirk

AU - Roy, Amitesh C.

AU - Guren, Marianne Grønlie

AU - Segelov, Eva

AU - Seymour, Matthew T

AU - Bryant, Annette

AU - Peckitt, Clare

AU - Cunningham, David

AU - Bridgewater, John A.

PY - 2015

Y1 - 2015

U2 - 10.1200/jco.2015.33.3_suppl.tps792

DO - 10.1200/jco.2015.33.3_suppl.tps792

M3 - Poster

ER -

Scalafini F, Adams RA, Eng C, Benson III A, Glynne-Jones RGT, Montefiori DC et al.. InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease. 2015. https://doi.org/10.1200/jco.2015.33.3_suppl.tps792